Cabozantinib | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Cabozantinib
Health Canada Patents

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

IOL Chemicals is an innovation-driven bulk drug, Intermediate and Specialty Chemicals company.

Contact Supplier

IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Coral

Contact Supplier

ICE Pharma offers a unique range of bile acid products and best-in-class services for the pharmaceutical industry.

Contact Supplier

Cabozantinib

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 11 USDMF, 5 EU WC, 3 KDMF, 14 NDC API, 24 Listed Suppliers, $ API Reference Price

42 API Suppliers
11 USDMF
5 EU WC
3 KDMF
14 NDC API
24 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

205 Drugs in Development

205 Drugs in Development

INTERMEDIATES

24 Intermediate Suppliers

24 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

52 FDF Dossiers, 10 FDA Orange Book, 14 Europe, 3 Canada, 12 Australia, 3 South Africa, 10 Listed Dossiers

52 FDF Dossiers
10 FDA Orange Book
14 Europe
3 Canada
12 Australia
3 South Africa
10 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 20MG BASE, CAPSULE;ORAL - EQ 80MG BASE

CAPSULE;ORAL - EQ 20MG BASE
CAPSULE;ORAL - EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 10 DKSH, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 4 ACG Worldwide, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 2 Ingredion Pharma Solutions, 14 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 2 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 14 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Coating Systems & Additives, 29 Fillers, Diluents & Binders, 23 Disintegrants & Superdisintegrants, 20 Thickeners and Stabilizers, 17 Direct Compression, 14 Lubricants & Glidants, 14 Granulation, 14 Controlled & Modified Release, 11 Film Formers & Plasticizers, 9 Empty Capsules, 7 Co-Processed Excipients, 6 Emulsifying Agents, 5 Coloring Agents, 5 Rheology Modifiers, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Taste Masking, 4 Topical, 3 Solubilizers, 1 Parenteral

42 Coating Systems & Additives
29 Fillers, Diluents & Binders
23 Disintegrants & Superdisintegrants
20 Thickeners and Stabilizers
17 Direct Compression
14 Lubricants & Glidants
14 Granulation
14 Controlled & Modified Release
11 Film Formers & Plasticizers
9 Empty Capsules
7 Co-Processed Excipients
6 Emulsifying Agents
5 Coloring Agents
5 Rheology Modifiers
4 Chewable & Orodispersible Aids
4 Vegetarian Capsules
4 API Stability Enhancers
4 Taste Masking
4 Topical
3 Solubilizers
1 Parenteral

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 171 News #PharmaBuzz

2 Data Compilation #PharmaFlow
171 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 6 Regulatory FDF Prices, 12 Annual Reports

2 US Medicaid Prescriptions
6 Regulatory FDF Prices
12 Annual Reports

MARKET PLACE

8 APIs, 2 FDF Dossiers

8 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

76 US Patents, 6 US Exclusivities, 12 Health Canada Patents

76 US Patents
6 US Exclusivities
12 Health Canada Patents

REF. STANDARDS & IMPURITIES

10 Others

10 Others

$ API Ref.Price (USD/KG) : 18,513 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

12 All

01 12Smart & Biggar LLP

filter Patent Reset all filters

12 All

01 32537812

02 32758030

03 32805645

04 32834778

filter Product Reset all filters

12 All

01 12CABOZANTINIB MALATE

filter Dosage Reset all filters

12 All

01 12TABLET

filter Exp Date Reset all filters

12 All

01 32024-09-24

02 32030-01-15

03 32031-07-18

04 32032-05-02

Product Main Page

01

Smart & Biggar LLP

CABOZANTINIB MALATE

Formnext Forum

Not Confirmed

Smart & Biggar LLP

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-07-18

Date Granted : 2019-05-07

CABOZANTINIB MALATE

Brand Name : CABOMETYX

Patent Number : 2805645

Filing Date : 2011-07-18

Strength per Unit : 20 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-07-18

Date Granted : 2019-05-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Smart & Biggar LLP

CABOZANTINIB MALATE

Formnext Forum

Not Confirmed

Smart & Biggar LLP

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-01-15

Date Granted : 2019-01-08

CABOZANTINIB MALATE

Brand Name : CABOMETYX

Patent Number : 2758030

Filing Date : 2010-01-15

Strength per Unit : 20 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-01-15

Date Granted : 2019-01-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Smart & Biggar LLP

CABOZANTINIB MALATE

Formnext Forum

Not Confirmed

Smart & Biggar LLP

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-09-24

Date Granted : 2013-01-22

CABOZANTINIB MALATE

Brand Name : CABOMETYX

Patent Number : 2537812

Filing Date : 2004-09-24

Strength per Unit : 20 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-09-24

Date Granted : 2013-01-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Smart & Biggar LLP

CABOZANTINIB MALATE

Formnext Forum

Not Confirmed

Smart & Biggar LLP

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-05-02

Date Granted : 2019-08-13

CABOZANTINIB MALATE

Brand Name : CABOMETYX

Patent Number : 2834778

Filing Date : 2012-05-02

Strength per Unit : 20 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-05-02

Date Granted : 2019-08-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Smart & Biggar LLP

CABOZANTINIB MALATE

Formnext Forum

Not Confirmed

Smart & Biggar LLP

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-07-18

Date Granted : 2019-05-07

CABOZANTINIB MALATE

Brand Name : CABOMETYX

Patent Number : 2805645

Filing Date : 2011-07-18

Strength per Unit : 40 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-07-18

Date Granted : 2019-05-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Smart & Biggar LLP

CABOZANTINIB MALATE

Formnext Forum

Not Confirmed

Smart & Biggar LLP

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-01-15

Date Granted : 2019-01-08

CABOZANTINIB MALATE

Brand Name : CABOMETYX

Patent Number : 2758030

Filing Date : 2010-01-15

Strength per Unit : 40 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-01-15

Date Granted : 2019-01-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

Smart & Biggar LLP

CABOZANTINIB MALATE

Formnext Forum

Not Confirmed

Smart & Biggar LLP

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2024-09-24

Date Granted : 2013-01-22

CABOZANTINIB MALATE

Brand Name : CABOMETYX

Patent Number : 2537812

Filing Date : 2004-09-24

Strength per Unit : 40 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-09-24

Date Granted : 2013-01-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

Smart & Biggar LLP

CABOZANTINIB MALATE

Formnext Forum

Not Confirmed

Smart & Biggar LLP

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-05-02

Date Granted : 2019-08-13

CABOZANTINIB MALATE

Brand Name : CABOMETYX

Patent Number : 2834778

Filing Date : 2012-05-02

Strength per Unit : 40 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2032-05-02

Date Granted : 2019-08-13

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

Smart & Biggar LLP

CABOZANTINIB MALATE

Formnext Forum

Not Confirmed

Smart & Biggar LLP

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-07-18

Date Granted : 2019-05-07

CABOZANTINIB MALATE

Brand Name : CABOMETYX

Patent Number : 2805645

Filing Date : 2011-07-18

Strength per Unit : 60 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2031-07-18

Date Granted : 2019-05-07

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

Smart & Biggar LLP

CABOZANTINIB MALATE

Formnext Forum

Not Confirmed

Smart & Biggar LLP

Country

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-01-15

Date Granted : 2019-01-08

CABOZANTINIB MALATE

Brand Name : CABOMETYX

Patent Number : 2758030

Filing Date : 2010-01-15

Strength per Unit : 60 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2030-01-15

Date Granted : 2019-01-08

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!